Endogenous interleukin-10 is required for the defervescence of fever evoked by local lipopolysaccharide-induced and Staphylococcus aureus-induced inflammation in rats

被引:48
作者
Cartmell, T
Ball, C
Bristow, AF
Mitchell, D
Poole, S
机构
[1] Natl Inst Biol Stand & Controls, Blanche Lane, Potters Bar EN6 3QG, Herts, England
[2] Univ Witwatersrand, Sch Med, Brain Funct Res Unit, Sch Physiol, ZA-2193 Johannesburg, South Africa
来源
JOURNAL OF PHYSIOLOGY-LONDON | 2003年 / 549卷 / 02期
关键词
D O I
10.1113/jphysiol.2002.037291
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We tested the hypothesis that endogenous interleukin (IL)-10 limits the fever induced by a Gramnegative bacterial toxin (Escherichia coli lipopolysaccharide, LPS) and a Gram-positive bacterial toxin (Staphylococcus aureus), when these toxins are injected into a subcutaneous air pouch (I.P.O.) in rats. Injection of LPS or S. aureus caused fevers that were reduced in amplitude and duration by simultaneous administration of rat recombinant IL-10. The inhibition of fever by IL-10 was accompanied by a significant reduction in the toxin-evoked increases in concentrations of immunoreactive IL-6 at the site of inflammation and of IL-6 and IL-1 receptor antagonist in the circulation. Conversely, neutralisation of endogenous IL-10 in the pouch increased the amplitude and dramatically increased the duration of toxin-evoked fever, and augmented toxin-induced increases in pouch tumour necrosis factor-alpha, IL-1beta, and especially IL-6. Our data support a crucial regulatory role for endogenous IL-10 in limiting the fever responses during both Gram-negative and Gram-positive infections.
引用
收藏
页码:653 / 664
页数:12
相关论文
共 68 条
[1]   Mammalian Toll-like receptors [J].
Akira, S .
CURRENT OPINION IN IMMUNOLOGY, 2003, 15 (01) :5-11
[2]  
AREND W P, 1990, Progress in Growth Factor Research, V2, P193, DOI 10.1016/0955-2235(90)90018-F
[3]  
Ball C, 2001, EUR CYTOKINE NETW, V12, P187
[4]   Effects of treatment with a fully human anti-tumour necrosis factor α monoclonal antibody on the local and systemic homeostasis of interleukin 1 and TNFα in patients with rheumatoid arthritis [J].
Barrera, P ;
Joosten, LAB ;
den Broeder, AA ;
van de Putte, LBA ;
van Riel, PLCM ;
van den Berg, WB .
ANNALS OF THE RHEUMATIC DISEASES, 2001, 60 (07) :660-669
[5]   INTERLEUKIN-10 IS A CENTRAL REGULATOR OF THE RESPONSE TO LPS IN MURINE MODELS OF ENDOTOXIC-SHOCK AND THE SHWARTZMAN REACTION BUT NOT ENDOTOXIN TOLERANCE [J].
BERG, DJ ;
KUHN, R ;
RAJEWSKY, K ;
MULLER, W ;
MENON, S ;
DAVIDSON, N ;
GRUNIG, G ;
RENNICK, D .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 96 (05) :2339-2347
[6]   INFECTION WITH MYCOBACTERIUM-AVIUM INDUCES PRODUCTION OF INTERLEUKIN-10 (IL-10), AND ADMINISTRATION OF ANTI-IL-10 ANTIBODY IS ASSOCIATED WITH ENHANCED RESISTANCE TO INFECTION IN MICE [J].
BERMUDEZ, LE ;
CHAMPSI, J .
INFECTION AND IMMUNITY, 1993, 61 (07) :3093-3097
[7]   Vagotomy blocks behavioural effects of interleukin-1 injected via the intraperitoneal route but not via other systemic routes [J].
Bluthe, RM ;
Michaud, B ;
Kelley, KW ;
Dantzer, R .
NEUROREPORT, 1996, 7 (15-17) :2823-2827
[8]   Circulating interleukin-6 mediates the febrile response to localised inflammation in rats [J].
Cartmell, T ;
Poole, S ;
Turnbull, AV ;
Rothwell, NJ ;
Luheshi, GN .
JOURNAL OF PHYSIOLOGY-LONDON, 2000, 526 (03) :653-661
[9]   Role of endogenous interleukin-1 receptor antagonist in regulating fever induced by localised inflammation in the rat [J].
Cartmell, T ;
Luheshi, GN ;
Hopkins, SJ ;
Rothwell, NJ ;
Poole, S .
JOURNAL OF PHYSIOLOGY-LONDON, 2001, 531 (01) :171-180
[10]   INTERLEUKIN-10 (IL-10) UP-REGULATES IL-1 RECEPTOR ANTAGONIST PRODUCTION FROM LIPOPOLYSACCHARIDE-STIMULATED HUMAN POLYMORPHONUCLEAR LEUKOCYTES BY DELAYING MESSENGER-RNA DEGRADATION [J].
CASSATELLA, MA ;
MEDA, L ;
GASPERINI, S ;
CALZETTI, F ;
BONORA, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (05) :1695-1699